Phototherapy Treatment Market
Market Insights on Phototherapy Treatment covering sales outlook, demand forecast & up-to-date key trends
Phototherapy Treatment Market By Disease Type, Phototherapy, End User & Region - Forecast 2022 - 2026
Phototherapy Treatment Market Outlook (2022-2026)
[102 Pages Report] The phototherapy treatment market is slated to reach US$ 530 Million by 2022-end, and is further expected to surge at a value CAGR of 5% until 2026. A closing valuation worth US$ 675 Million is anticipated for the market by 2026. Market growth of phototherapy equipment is primarily driven by the following key factors:
- The rising prevalence of acne and psoriasis across all regions as well as rising skin hygiene awareness
- Rising deployment of various combination therapies to yield more successful surgical outcomes
- Extensive application for treating neonatal jaundice, as well as prevention of neurotoxic effects of high serum unconjugated bilirubin
- High preference for blue light phototherapy is expected to take a turn for the better in the coming decade
|
Attribute |
Details |
|
Estimated Market Size of Phototherapy Treatment Market in 2021 |
US$ 530 Mn |
|
Projected Market Size of Phototherapy Treatment Market in 2026 |
US$ 675 Bn |
|
CAGR during 2021-2022 |
5% |
Let us know your requirement to get
100% FREE customization
Compounding Skin Problems within Patients increasing reliance on Phototherapy Treatment
Skin diseases are among the most common of all human health afflictions and affect almost 900 million people in the world at any time. Five common conditions account for over 80% of all skin diseases. These may cause rashes, inflammation, itchiness or other skin changes. Some skin conditions may be genetic, while lifestyle factors may cause others. Skin disease treatment may include medications, creams or ointments, or lifestyle changes.
However, in recent years, phototherapy has emerged as a highly effective approach to addressing many skin problems. Phototherapy uses light waves to treat certain skin conditions. The skin is exposed to an ultraviolet (UV) light for a set amount of time. Phototherapy uses a man-made source of UV light. UV light also comes from the sun. When combined with a medication called psoralen, the procedure is known as psoralen UVA (PUVA).
UV light shuts down immune system cells in the skin. It can help in skin conditions that are caused by an overreaction of the immune system. Some condition which can be cured using this approach include psoriasis, eczema, mycosis fungoides and vitiligo among others.
Newborn Jaundice Treatment a Key Application Area for Phototherapy Treatment
According to the National Health Survey, neonatal jaundice is one of the most common conditions affecting newborn babies. It is estimated that 6 out of 10 infants develop jaundice, including 8 out of 10 premature ones before the 37th week of pregnancy. Treatment for newborn jaundice is not usually needed because the symptoms normally pass within 10 to 14 days, although they can occasionally last longer. Treatment is usually only recommended if tests show very high levels of bilirubin in a baby's blood.
In case it is required, phototherapy is relied upon as an effective approach. This treatment is generally considered safe, as it only involves exposing the body to light which alters the composition of bilirubin, making it easy to excrete. Usually, phototherapy is the only medical treatment needed. A small number of babies with severe jaundice need blood transfusions to replace red blood cells that have been used up, and to dilute out the bilirubin.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystNorth America and Europe to be Key Beneficiaries of Market Growth
Through 2026, the phototherapy treatment market in North America and Europe is predicted to grow at a CAGR of 6%. The USA presently controls 35% of the revenue in the North American phototherapy treatment market.
This recent trend is boosting the phototherapy segment. While in the U.S. the growing population of adult women suffering from acne and psoriasis is an important factor driving revenue growth of the phototherapy segment. The population of adult women is rising with higher rates in North America than in European countries such as Germany, Italy, France and Spain. The growth in women adult acne conditions in North America is mainly due to increase in male hormonal (androgens) levels in females.
Through 2027, the phototherapy treatment market in North America and Europe is predicted to grow at a CAGR of 6% reaching US$ 1 Billion.
The USA presently controls 35% of the revenue in the North American phototherapy treatment market. The market for Acne and Psoriasis is expected to reach US$ 2.5 billion through 2027.
Through 2027, the blue light phototherapy segment is expected to have a market value of US$ 1 Bn
This recent trend is boosting the phototherapy segment. While in the U.S. the growing population of adult women suffering from acne and psoriasis is an important factor driving revenue growth of the phototherapy segment.
The population of adult women is rising with higher rates in North America than in European countries such as Germany, Italy, France and Spain. The growth in women adult acne conditions in North America is mainly due to increase in male hormonal (androgens) levels in females.
Complementary therapies to treat psoriasis conditions and combination therapies are recent trends in Western Europe, which are creating a positive impact on the phototherapy segment in the regional market
Complementary therapies such as balneotherapy along with UV radiation is quite popular in Western European countries. Balneotherapy is the oldest treatment method available to treat the psoriasis condition. In this treatment, the patient undergoes a bath in high mineralized brine, which causes a mechanical removal of skin scales and increases the sensitivity of skin to UV radiation.
Combination therapies are set to witness high potential in austerity driven markets in Europe as noted by many clinic managers. Faltering out-of-pocket expenses for a service that is considered as a desire or luxury coupled with a tricky pricing of combination treatments involving a device and a drug are factors successfully helping in generating revenue in the market. This trend is very prominent in countries such as the U.K. and Spain.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Approved by the FDA to treat acne and psoriasis, blue light therapy dominates the North America and Europe phototherapy treatment market
By phototherapy type, blue light therapy dominated the North America and Europe phototherapy treatment market for psoriasis and acne, and is expected to be the most lucrative segment over the forecast period, with a market attractiveness index of 3.3. By the end of 2027, the blue light phototherapy segment is projected to reach more than US$ 1,000 Mn, expanding at a CAGR of 6.7% over the forecast period.
Revenue from the Narrowband UVB phototherapy segment in the North America and Europe phototherapy treatment market for psoriasis and acne is expected to grow 1.9x by 2027 end as compared to that in 2017. The Red Light Phototherapy and Intense Pulsed Light (IPL) Phototherapy segments represent the lowest market attractiveness index of 0.3 each.
Availability of various treatments for acne and psoriasis and declining reimbursement rates are expected to hamper the growth of the phototherapy segment
Various treatments are currently available in the market to treat acne and psoriasis conditions. For instance, to treat acne conditions various drugs are available in the market such as topical/oral antibiotics and retinoid and chemical peels, among others. Due to a lot of available treatment options, physicians prescribe different treatments according to the patient’s skin nature and availability of drugs.
Owing to the many treatment options, very few physicians prescribe phototherapy to patients. Furthermore, availability of non-office based treatments to treat acne and psoriasis conditions has a negative impact on the growth of the phototherapy segment. Furthermore, the decline of reimbursement pay and lack of adequate phototherapy units in the market are projected to hamper revenue growth of the phototherapy segment over the forecast period.
North America and Europe Phototherapy Treatment for Acne and Psoriasis Market – Taxonomy
By Disease Type
- Psoriasis
- Guttate Psoriasis
- Inverse Psoriasis
- Pustular Psoriasis
- Erythrodermic Psoriasis
- Plaque Psoriasis
- Acne
- Acne Vulgaris
- Acne Conglobata
- Acne Fulminans
- Gram-Negative Folliculitis
- Acne Rosacea
- Pyoderma Faciale
By Phototherapy Type
- Blue Light Phototherapy
- Red Light Phototherapy
- Intense Pulsed Light (IPL) Phototherapy
- Narrowband UVB Phototherapy
- Psoralens+Ultravioletlight A (PUVA) Phototherapy
By End User
- Hospitals
- Dermatology Clinics/Skin Care Centres
- Wellness Centres
- Home Care Settings
By Region
- North America
- Western Europe
- Eastern Europe
Frequently Asked Questions
The phototherapy treatment market is valued at US$ 530 Million in 2021. The market is likely to grow at a CAGR of 5% through 2026, reaching US$ 675 Million.
Lifespan, UVC Irvine Health, Buffalo Medical Corp. and National Skin Centre are some prominent phototherapy treatment providers in the market
Table of Content
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
2.3. Phototherapy Treatment Market Overview
3. Medical Bionic Implants & Exoskeletons Market View Point
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Pricing Assumptions
4. North America Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027
4.1. Introduction
4.2. Regional Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
4.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
4.3.1. U.S.
4.3.2. Canada
4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
4.4.1. U.S.
4.4.2. Canada
4.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016
4.5.1. Psoriasis
4.5.1.1. Guttate Psoriasis
4.5.1.2. Inverse Psoriasis
4.5.1.3. Pustular Psoriasis
4.5.1.4. Erythrodermic Psoriasis
4.5.1.5. Plaque Psoriasis
4.5.2. Acne
4.5.2.1. Acne Vulgaris
4.5.2.2. Acne Conglobata
4.5.2.3. Acne Fulminans
4.5.2.4. Gram-Negative Folliculitis
4.5.2.5. Acne Rosacea
4.5.2.6. Pyoderma Faciale
4.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027
4.6.1. Psoriasis
4.6.1.1. Guttate Psoriasis
4.6.1.2. Inverse Psoriasis
4.6.1.3. Pustular Psoriasis
4.6.1.4. Erythrodermic Psoriasis
4.6.1.5. Plaque Psoriasis
4.6.2. Acne
4.6.2.1. Acne Vulgaris
4.6.2.2. Acne Conglobata
4.6.2.3. Acne Fulminans
4.6.2.4. Gram-Negative Folliculitis
4.6.2.5. Acne Rosacea
4.6.2.6. Pyoderma Faciale
4.7. Historical Market Size (US$ Mn) Analysis By Phototherapy, 2012-2016
4.7.1. Blue Light Phototherapy
4.7.2. Red Light Phototherapy
4.7.3. Intense Pulsed Light (IPL) Phototherapy
4.7.4. Combination Treatment
4.7.5. Narrowband UVB Phototherapy
4.7.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy
4.7.7. Others
4.8. Market Size (US$ Mn) Forecast By Phototherapy, 2017-2027
4.8.1. Blue Light Phototherapy
4.8.2. Red Light Phototherapy
4.8.3. Intense Pulsed Light (IPL) Phototherapy
4.8.4. Combination Treatment
4.8.5. Narrowband UVB Phototherapy
4.8.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy
4.8.7. Others
4.9. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016
4.9.1. Hospitals
4.9.2. Dermatology Clinics/Skin Care Centers
4.9.3. Wellness Centers
4.9.4. Home Care Settings
4.10. Market Size (US$ Mn) Forecast By End User, 2017-2027
4.10.1. Hospitals
4.10.2. Dermatology Clinics/Skin Care Centers
4.10.3. Wellness Centers
4.10.4. Home Care Settings
4.11. Market Attractiveness Analysis
4.11.1. By Country
4.11.2. By Disease Type
4.11.3. By Phototherapy
4.11.4. By End User
5. Western Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027
5.1. Introduction
5.2. Regional Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Trends
5.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
5.3.1. Germany
5.3.2. United Kingdom
5.3.3. France
5.3.4. Italy
5.3.5. Spain
5.3.6. Nordics
5.3.7. BENELUX
5.3.8. Rest of Western Europe
5.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
5.4.1. Germany
5.4.2. United Kingdom
5.4.3. France
5.4.4. Italy
5.4.5. Spain
5.4.6. Nordics
5.4.7. BENELUX
5.4.8. Rest of Western Europe
5.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016
5.5.1. Psoriasis
5.5.1.1. Guttate Psoriasis
5.5.1.2. Inverse Psoriasis
5.5.1.3. Pustular Psoriasis
5.5.1.4. Erythrodermic Psoriasis
5.5.1.5. Plaque Psoriasis
5.5.2. Acne
5.5.2.1. Acne Vulgaris
5.5.2.2. Acne Conglobata
5.5.2.3. Acne Fulminans
5.5.2.4. Gram-Negative Folliculitis
5.5.2.5. Acne Rosacea
5.5.2.6. Pyoderma Faciale
5.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027
5.6.1. Psoriasis
5.6.1.1. Guttate Psoriasis
5.6.1.2. Inverse Psoriasis
5.6.1.3. Pustular Psoriasis
5.6.1.4. Erythrodermic Psoriasis
5.6.1.5. Plaque Psoriasis
5.6.2. Acne
5.6.2.1. Acne Vulgaris
5.6.2.2. Acne Conglobata
5.6.2.3. Acne Fulminans
5.6.2.4. Gram-Negative Folliculitis
5.6.2.5. Acne Rosacea
5.6.2.6. Pyoderma Faciale
5.7. Historical Market Size (US$ Mn) Analysis By Phototherapy, 2012-2016
5.7.1. Blue Light Phototherapy
5.7.2. Red Light Phototherapy
5.7.3. Intense Pulsed Light (IPL) Phototherapy
5.7.4. Combination Treatment
5.7.5. Narrowband UVB Phototherapy
5.7.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy
5.7.7. Others
5.8. Market Size (US$ Mn) Forecast By Phototherapy, 2017-2027
5.8.1. Blue Light Phototherapy
5.8.2. Red Light Phototherapy
5.8.3. Intense Pulsed Light (IPL) Phototherapy
5.8.4. Combination Treatment
5.8.5. Narrowband UVB Phototherapy
5.8.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy
5.8.7. Others
5.9. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016
5.9.1. Hospitals
5.9.2. Dermatology Clinics/Skin Care Centers
5.9.3. Wellness Centers
5.9.4. Home Care Settings
5.10. Market Size (US$ Mn) Forecast By End User, 2017-2027
5.10.1. Hospitals
5.10.2. Dermatology Clinics/Skin Care Centers
5.10.3. Wellness Centers
5.10.4. Home Care Settings
5.11. Market Attractiveness Analysis
5.11.1. By Country
5.11.2. By Disease Type
5.11.3. By Phototherapy
5.11.4. By End User
6. Eastern Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027
6.1. Introduction
6.2. Regional Market Dynamics
6.2.1. Drivers
6.2.2. Restraints
6.2.3. Trends
6.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
6.3.1. Russia
6.3.2. Poland
6.3.3. Rest of Eastern Europe
6.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
6.4.1. Russia
6.4.2. Poland
6.4.3. Rest of Eastern Europe
6.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016
6.5.1. Psoriasis
6.5.1.1. Guttate Psoriasis
6.5.1.2. Inverse Psoriasis
6.5.1.3. Pustular Psoriasis
6.5.1.4. Erythrodermic Psoriasis
6.5.1.5. Plaque Psoriasis
6.5.2. Acne
6.5.2.1. Acne Vulgaris
6.5.2.2. Acne Conglobata
6.5.2.3. Acne Fulminans
6.5.2.4. Gram-Negative Folliculitis
6.5.2.5. Acne Rosacea
6.5.2.6. Pyoderma Faciale
6.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027
6.6.1. Psoriasis
6.6.1.1. Guttate Psoriasis
6.6.1.2. Inverse Psoriasis
6.6.1.3. Pustular Psoriasis
6.6.1.4. Erythrodermic Psoriasis
6.6.1.5. Plaque Psoriasis
6.6.2. Acne
6.6.2.1. Acne Vulgaris
6.6.2.2. Acne Conglobata
6.6.2.3. Acne Fulminans
6.6.2.4. Gram-Negative Folliculitis
6.6.2.5. Acne Rosacea
6.6.2.6. Pyoderma Faciale
6.7. Historical Market Size (US$ Mn) Analysis By Phototherapy, 2012-2016
6.7.1. Blue Light Phototherapy
6.7.2. Red Light Phototherapy
6.7.3. Intense Pulsed Light (IPL) Phototherapy
6.7.4. Combination Treatment
6.7.5. Narrowband UVB Phototherapy
6.7.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy
6.7.7. Others
6.8. Market Size (US$ Mn) Forecast By Phototherapy, 2017-2027
6.8.1. Blue Light Phototherapy
6.8.2. Red Light Phototherapy
6.8.3. Intense Pulsed Light (IPL) Phototherapy
6.8.4. Combination Treatment
6.8.5. Narrowband UVB Phototherapy
6.8.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy
6.8.7. Others
6.9. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016
6.9.1. Hospitals
6.9.2. Dermatology Clinics/Skin Care Centers
6.9.3. Wellness Centers
6.9.4. Home Care Settings
6.10. Market Size (US$ Mn) Forecast By End User, 2017-2027
6.10.1. Hospitals
6.10.2. Dermatology Clinics/Skin Care Centers
6.10.3. Wellness Centers
6.10.4. Home Care Settings
6.11. Market Attractiveness Analysis
6.11.1. By Country
6.11.2. By Disease Type
6.11.3. By Phototherapy
6.11.4. By End User
7. Forecast Factors: Relevance and Impact
8. Forecast Assumptions
9. Competition Landscape
9.1. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
9.1.1. Lifespan
9.1.2. UC Irvine Health
9.1.3. Buffalo Medical Group
9.1.4. Blackrock Clinic Limited
9.1.5. The Private Phototherapy Clinic Ltd
9.1.6. National Skin Centre
9.1.7. Massachusetts General Hospital
10. North America and Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027, By Region
10.1. Historical Market Size (US$ Mn) Analysis By Region, 2012-2016
10.1.1. North America
10.1.2. Western Europe
10.1.3. Eastern Europe
10.2. Market Size (US$ Mn) Forecast By Region, 2017-2027
10.2.1. North America
10.2.2. Western Europe
10.2.3. Eastern Europe
10.3. Market Attractiveness Analysis By Region
11. North America and Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027, By Disease
11.1. Introduction/Key Finding
11.2. Historical Market Size (US$ Mn) Analysis By Disease, 2012-2016
11.2.1. Psoriasis
11.2.1.1. Guttate Psoriasis
11.2.1.2. Inverse Psoriasis
11.2.1.3. Pustular Psoriasis
11.2.1.4. Erythrodermic Psoriasis
11.2.1.5. Plaque Psoriasis
11.2.2. Acne
11.2.2.1. Acne Vulgaris
11.2.2.2. Acne Conglobata
11.2.2.3. Acne Fulminans
11.2.2.4. Gram-Negative Folliculitis
11.2.2.5. Acne Rosacea
11.2.2.6. Pyoderma Faciale
11.3. Market Size (US$ Mn) Forecast By Disease, 2017-2027
11.3.1. Psoriasis
11.3.1.1. Guttate Psoriasis
11.3.1.2. Inverse Psoriasis
11.3.1.3. Pustular Psoriasis
11.3.1.4. Erythrodermic Psoriasis
11.3.1.5. Plaque Psoriasis
11.3.2. Acne
11.3.2.1. Acne Vulgaris
11.3.2.2. Acne Conglobata
11.3.2.3. Acne Fulminans
11.3.2.4. Gram-Negative Folliculitis
11.3.2.5. Acne Rosacea
11.3.2.6. Pyoderma Faciale
11.4. Market Attractiveness Analysis By Disease
12. North America and Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027, By Phototherapy
12.1. Introduction/Key Finding
12.2. Historical Market Size (US$ Mn) Analysis By Mode, 2012-2016
12.2.1. Blue Light Phototherapy
12.2.2. Red Light Phototherapy
12.2.3. Intense Pulsed Light (IPL) Phototherapy
12.2.4. Combination Treatment
12.2.5. Narrowband UVB Phototherapy
12.2.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy
12.2.7. Others
12.3. Market Size (US$ Mn) Forecast By Mode, 2017-2027
12.3.1. Blue Light Phototherapy
12.3.2. Red Light Phototherapy
12.3.3. Intense Pulsed Light (IPL) Phototherapy
12.3.4. Combination Treatment
12.3.5. Narrowband UVB Phototherapy
12.3.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy
12.3.7. Others
12.4. Market Attractiveness Analysis By Phototherapy
13. North America and Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027, By End User
13.1. Introduction/Key Finding
13.2. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016
13.2.1. Hospitals
13.2.2. Dermatology Clinics/Skin Care Centers
13.2.3. Wellness Centers
13.2.4. Home Care Settings
13.3. Market Size (US$ Mn) Forecast By End User, 2017-2027
13.3.1. Hospitals
13.3.2. Dermatology Clinics/Skin Care Centers
13.3.3. Wellness Centers
13.3.4. Home Care Settings
13.4. Market Attractiveness Analysis By End User
14. Assumptions and Acronyms Used
15. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: North America Phototherapy Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country
Table 2: North America Phototherapy Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type
Table 3: North America Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Phototherapy
Table 4: North America Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User
Table 5: Western Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country
Table 6: Western Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type
Table 7: Western Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Phototherapy
Table 8: Western Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User
Table 9: Eastern Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country
Table 10: Eastern Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type
Table 11: Eastern Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Phototherapy
Table 12: Eastern Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User
Table 13: North America and Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Region
Table 14: North America and Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease
Table 15: North America and Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Phototherapy
Table 16: North America and Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: North America and Europe Phototherapy Market Value Analysis and Forecast, 2017–2027 (US$ Mn)
Figure 2: North America Phototherapy Treatment Market Share Analysis (%) By Country, 2017–2027
Figure 3: North America Phototherapy Treatment Market Y-o-Y Growth (%) By Country, 2017–2027
Figure 4: North America Phototherapy Treatment Market Size Analysis (%) 2012–2016
Figure 5: North America Phototherapy Treatment Market Y-o-Y Growth (%), 2017–2027
Figure 6: North America Phototherapy Treatment Market Attractiveness Analysis, By Country
Figure 7: North America Phototherapy Treatment Market Attractiveness Analysis, By Phototherapy
Figure 8: North America Phototherapy Treatment Market Attractiveness Analysis, By Disease Type
Figure 9: North America Phototherapy Treatment Market Attractiveness Analysis, By End User
Figure 10: Western Europe Phototherapy Treatment Market Share Analysis (%) By Country, 2017–2027
Figure 11: Western Europe Phototherapy Treatment Market Y-o-Y Growth (%) By Country, 2017–2027
Figure 12: Western Europe Phototherapy Treatment Market Size Analysis (%), 2012–2016
Figure 13: Western Europe Phototherapy Treatment Market Y-o-Y Growth (%), 2017–2027
Figure 14: Western Europe Phototherapy Treatment Market Attractiveness Analysis, By Country
Figure 15: Western Europe Phototherapy Treatment Market Attractiveness Analysis, By Phototherapy
Figure 16: Western Europe Phototherapy Treatment Market Attractiveness Analysis, By Disease Type
Figure 17: Western Europe Phototherapy Treatment Market Attractiveness Analysis, By End User
Figure 18: Acne and Psoriasis Prevalence Rates in Eastern Europe Region, 2015
Figure 19: Psoriasis Patients in Eastern Europe Region, 2010 & 2015
Figure 20: Eastern Europe Phototherapy Treatment Market Share Analysis (%) By Country, 2017–2027
Figure 21: Eastern Europe Phototherapy Treatment Market Y-o-Y Growth (%) By Country, 2017–2027
Figure 22: Eastern Europe Phototherapy Treatment Market Size Analysis (%), 2012–2016
Figure 23: Eastern Europe Phototherapy Treatment Market Y-o-Y Growth (%), 2017–2027
Figure 24: Eastern Europe Phototherapy Treatment Market Attractiveness Analysis, By Country
Figure 25: Eastern Europe Phototherapy Treatment Market Attractiveness Analysis, By Phototherapy
Figure 26: Eastern Europe Phototherapy Treatment Market Attractiveness Analysis, By Disease Type
Figure 27: Eastern Europe Phototherapy Treatment Market Attractiveness Analysis, By End User
Figure 28: North America and Europe Phototherapy Treatment Market Attractiveness Analysis, By Region
Figure 29: North America and Europe Phototherapy Treatment Market Attractiveness Analysis, Disease
Figure 30: North America and Europe Phototherapy Treatment Market Attractiveness Analysis, By Phototherapy
Figure 31: North America and Europe Phototherapy Treatment Market Attractiveness Analysis, By End User
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
